Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers

NCT03826719 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: NBP607QIV
BIOLOGICAL: Agrippal

Sponsor

SK Chemicals Co., Ltd.